HotHouse Therapeutics
PrivateLast Round
Pre Seed
Dec 2, 2025
Total Funding Raised
$3.88M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
HotHouse Therapeutics operates in Healthcare & Life Sciences and is based in Norwich. Its latest recorded funding round was a Pre Seed round in December 2025.
HotHouse Therapeutics is a biotechnology company that develops plant-based therapeutics using AI-driven biosynthetic pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HotHouse Therapeutics Comparables
Compare HotHouse Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunAdd Inc. | 81% | |
| Adjuvance Technologies | 77% | |
| Leaf Expression Systems | 77% |
For institutional investors. Book with your work email.
HotHouse Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
HotHouse Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Pre Seed |
| Start Codon | Pre Seed |
| SynBioVen | Pre Seed |
| Innovate UK | Pre Seed |
| Twin Path Ventures | Pre Seed |
| Wren Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2025
$4M round led by SynBioVen.
For institutional investors. Book with your work email.
HotHouse Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HotHouse Therapeutics's valuation, stock price, and market status.
Is HotHouse Therapeutics a public or private company?
HotHouse Therapeutics is a private company.
What is the current stock price of HotHouse Therapeutics?
HotHouse Therapeutics is a private company, so its shares have no public market price. Caplight tracks HotHouse Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HotHouse Therapeutics worth (valuation)?
Valuation information for HotHouse Therapeutics is not publicly available.
Can I buy HotHouse Therapeutics stock?
HotHouse Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HotHouse Therapeutics's last funding round?
HotHouse Therapeutics's most recent funding round was Pre Seed on December 2, 2025.
Who are the main investors in HotHouse Therapeutics?
Key investors in HotHouse Therapeutics include SynBioVen.
Will HotHouse Therapeutics IPO soon?
No public IPO plans have been announced for HotHouse Therapeutics.
How can I track HotHouse Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in HotHouse Therapeutics's shares on secondary markets.